GenesisCare USA - Boca Ration FP06

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer5 trials
• Metastatic breast cancer1 trial
• Neuroendocrine tumours1 trial
• Pancreatic cancer1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting4 trials
• Terminated2 trials

Lead sponsor

• National Cancer Institute (NCI)6 trials

Running trials

• Active, not recruiting

  Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

  NCT04334941· Phase 2· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

  NCT04092283· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

  NCT03793179· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

  NCT03375320· Phase 3· National Cancer Institute (NCI)· Source

Closed trials

• Terminated

  Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

  NCT03737994· Phase 2· National Cancer Institute (NCI)· Source

• Terminated

  Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

  NCT03199885· Phase 3· National Cancer Institute (NCI)· Source